AVITA Medical (RCEL) EBITDA Margin Growth (5y) (2023 - 2025)
AVITA Medical (RCEL) EBITDA Margin Growth (5y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | AVITA Medical | 109.77 Mn | 91.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,903.00 |
| Sep 30, 2025 | 14,821.00 |
| Jun 30, 2025 | 27,538.00 |
| Mar 31, 2025 | 33,349.00 |
| Dec 31, 2024 | 51,151.00 |
| Sep 30, 2024 | 4,137.00 |
| Jun 30, 2024 | 20,231.00 |
| Mar 31, 2024 | 23,563.00 |
| Dec 31, 2023 | 51,931.00 |
| Sep 30, 2023 | 181,210.00 |